Acne Therapeutics Market Projected to Garner Significant Revenues by 2026

Press Release

Acne is a chronic inflammatory skin disease commonly affecting the adolescent and adult populations. Causes of acne formation include increase in sebum production, hyper keratinization, colonization by Propionibacterium acnes, and resulting inflammatory reaction. The global acne therapeutics market presents a lucrative opportunity for players in the dermatology care market owing to increase in adoption of acne cure products, changing lifestyles, and improvement in the economic standards of the global population.

Rise in prevalence of acne vulgaris, increase in research and development activities in advanced therapy areas, surge in the per capita spending on esthetics, availability of many OTC products, strong marketing & advertising campaigns, rich pipeline of molecules, regulations & guidelines for acne treatment, and favorable reimbursement scenario are projected to drive the global acne therapeutics market in the next few years. For instance, the American Academy of Dermatology (AAD) issued guidelines for treatment of acne occurring in both adolescents and adults in 2016. However, limitations of the drug discovery process such as high cost of the research process, uncertainty of results & time-consuming process; lack of trained dermatologists, and less awareness in some regions about available therapies are anticipated to restrain the market during the forecast period.

Download Brochure Copy of this Report:

The global acne therapeutics market can be segmented based on product type, route of administration, distribution channel, and region. In terms of therapy type, the market can be bifurcated into drug therapy and laser therapy. The drug therapy segment can be classified into antibiotic drugs, anti-inflammatory drugs, hormonal drugs, and others (retinoid, isotretinoin, steroids, chemical peels, etc.). Based on route of administration, the global acne therapeutics market can be categorized into oral, topical, and parenteral. In terms of distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to dominate the global market owing to high preference for hospital pharmacies for buying medical products.

In terms of region, the global acne therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America presents lucrative opportunities for players operating in the acne therapeutics market owing to high prevalence of acne among the population in the region, significant adoption of technologically advanced dermatological treatments, increase in new product launches, and high health care spending. According to the American Academy of Dermatology (AAD), acne is the most common skin disorder affecting the population in the U.S. Moreover, a survey conducted by AAD indicated that more than 5.1 million people in the country sought medical treatment for acne in 2013.

View TOC with Figures and Tables:

Europe is projected to be the second largest market for acne therapeutics owing to presence of large number of patients with acne, changing lifestyles, and increase in incidence of polycystic ovarian diseases in the region. Asia Pacific and Latin America are expected to be lucrative markets for acne therapeutics due to economic growth in countries in these regions, increase in population, and rise in health care awareness among the people.

Key players operating in the global acne therapeutics market include Allergan plc, GlaxoSmithKline plc, Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc., LEO Pharma A/S, Eli Lilly and Company, Bausch Health Companies, Inc., Sun Pharmaceuticals Ltd., Aclaris Therapeutics, Inc., and Aurobindo Pharma Ltd.

This post was originally published on The Market Plan